Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 21 October 2005:
Vol. 310. no. 5747, p. 419
DOI: 10.1126/science.310.5747.419b
Prev | Table of Contents | Next

ScienceScope

South Korea, whose scientists last year became the first to produce stem cells from cloned human embryos (Science, 13 February 2004, p. 937), is hoping to score more firsts in efforts to turn human embryonic stem (ES) cell research into treatments for disease. This week, Seoul National University was scheduled to announce the creation of a World Stem Cell Hub centered at the school's hospital, spearheaded by cloning pioneer Woo Suk Hwang and funded by the Korean government. Hwang and University of Pittsburgh stem cell researcher Gerald Schatten have collaborated on the plan, which will include facilities in Europe and the United States, as well as a stem cell bank and a program allowing Korean technicians to teach cloning and the cultivation of human ES cell lines.




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)